אלפאגן P

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

BRIMONIDINE TARTRATE

Disponibbli minn:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

Kodiċi ATC:

S01EA05

Għamla farmaċewtika:

תמיסה לעין

Kompożizzjoni:

BRIMONIDINE TARTRATE 0.15 %W/V

Rotta amministrattiva:

עיני

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

ALLERGAN INC., USA

Grupp terapewtiku:

BRIMONIDINE

Żona terapewtika:

BRIMONIDINE

Indikazzjonijiet terapewtiċi:

Alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Data ta 'l-awtorizzazzjoni:

2014-06-30

Fuljett ta 'informazzjoni

ALP
APL
APR
23
CL
Page 1 of 4
) )
"
-
1986
TM
P
:
w/v
0.15%
tartrate
brimonidine
:
6
'
'
.
.
.
,
.
/
.
.
/
.
1 . ?
P
.
:
-
.
2
.
:
−
)
(
(
6
‘
’
.)
−
.)
(
P ,
:
•
.
•
.
•
,
,
.
•
.
.
P
.
,
,
.
:
•
,
,
,
(
.)
•
.
•
.)
(
•
(
MAOI
.)
•
,
.
ALP APL APR
23
CL
Page 2 of 4
P
.
P
.
,
,
.
P
.
,
P
.
,
.
3
. ?
.
.
.
,
,
.
P
.
,
.
.
! :
P
.
.
:
1
.
.
2
.
.
3
.
.
4
,
.
(
)
1
2
.
.
,
.)
(
,
.
,
.
P
.
,
.
.
ALP APL APR
23
CL
Page 3 of 4 ! .
. . ,
4
.
,
P
.
.
.
.
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
.
:
(
very common
)
.
(
common
)
10
-
1
100
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
–
,
,
,
,
'
,
'
,
.
(
uncommon
)
10
-
1
1,000
.
,
, ,
. ,
"
"
)
www.health.gov.il
(
:
,
https://sideeffects.health.gov.il
5 . ?
•
!
.
/
.
•
exp. date)
.
)
.
•
:
C
25°
.
•
28
.
•
.
•
.
.
.
ALP APL APR
23
CL
Page 4 of 4
6 .
:
sodium chloride, sodium carboxymethylcellulose, boric acid, potassium
chloride,
sodium borate decahydrate, calcium chloride dihydrate, magnesium
chloride
hexahydrate, Purite

0.005%, hydrochloric acid and sodium hydroxide
to adjust pH,
purified water
:
P
-
5
,
"
10
"
15
.
.
"
:
'
,
"
4
,
.
,
:
.
"
,
2525
"
,
,
,
.
2023
.
:
131-06-30961-00
,
.
.